Cytochroma Inc.

Ontario – Toronto GTA – Markham

Corporation

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporation

active

Cytochroma Inc. is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.
Exporting: Yes
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Alternate Industries (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian companies and directors. Rate them and share your experience with other people.

Rating

Cytochroma Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Cytochroma Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytochroma Inc. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-COD-O-33679

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.